Journal article
Updates in keratin-positive mesenchymal neoplasia
Seminars in diagnostic pathology, Vol.43(3), 151009
05/2026
DOI: 10.1016/j.semdp.2026.151009
PMID: 41886900
Abstract
Increased access to and utilization of molecular testing in recent years has resulted in rapid discovery of fusion-driven entities in mesenchymal neoplasia. A subset of these rare tumors are defined by cytokeratin expression, which can lead to diagnostic overlap with more common keratin-positive neoplasms (poorly differentiated carcinomas, mesothelioma, etc). Recent examples include spindle cell rhabdomyosarcomas with TFCP2 fusions, keratin-positive giant-cell rich tumors with HMGA2::NCOR2 fusions, NR1D1- rearranged sarcomas, malignant epithelioid neoplasms with FET::CREB fusions, and the very recently described ossifying spindled and epithelioid tumors (OSET). This review will address the unique clinical, histologic, and immunophenotypic characteristics of these rare neoplasms and provide practical considerations for molecular testing in challenging cases of keratin-positive mesenchymal neoplasia.
Details
- Title: Subtitle
- Updates in keratin-positive mesenchymal neoplasia
- Creators
- Alexandra L. Isaacson - University of Iowa Health CareKaren J. Fritchie - Cleveland Clinic
- Resource Type
- Journal article
- Publication Details
- Seminars in diagnostic pathology, Vol.43(3), 151009
- DOI
- 10.1016/j.semdp.2026.151009
- PMID
- 41886900
- NLM abbreviation
- Semin Diagn Pathol
- ISSN
- 0740-2570
- eISSN
- 1930-1111
- Publisher
- Elsevier Inc
- Language
- English
- Electronic publication date
- 03/20/2026
- Date published
- 05/2026
- Academic Unit
- Pathology
- Record Identifier
- 9985149522102771
Metrics
3 Record Views